Search research articles
Contact Us
Filters
Showing results (1-10 of 168) with videos related to
Page
of 17
Sort By:
Journal of Geriatric Oncology
|
October 17, 2025
Response to letter to the editor: "Insights on nivolumab-based immunotherapy and prognostic stratification in older patients with metastatic renal cell carcinoma"
Veronica Murianni, Giuseppe Luigi Banna
The New England Journal of Medicine
|
October 23, 2024
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
Giuseppe Luigi Banna, Alfredo Addeo
Future Oncology (London, England)
|
August 14, 2015
How to develop novel treatments for EGFR-mutant lung cancer
Giuseppe Luigi Banna, Marcello Tiseo
Journal of Thoracic Disease
|
October 30, 2018
The crucial role of predicting brain metastases development in non-small cell lung cancer patients
Alfredo Addeo, Giuseppe Luigi Banna
Translational Lung Cancer Research
|
November 6, 2018
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Alfredo Addeo, Giuseppe Luigi Banna
Translational Lung Cancer Research
|
November 6, 2018
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Alfredo Addeo, Giuseppe Luigi Banna
The Oncologist
|
December 14, 2020
ADAURA: Mature Enough for Publication, Not for Prime Time
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Cancer Research
|
February 4, 2022
Stepping in the right direction but still some ways to go
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Lung Cancer Research
|
August 12, 2022
From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer
Giuseppe Luigi Banna, Jarushka Naidoo, Alfredo Addeo
Tumori
|
July 8, 2009
Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy
Matteo Simonelli, Giuseppe Luigi Banna, Armando Santoro
Page
of 17
Search research articles
Search
Showing results (1-10 of 168) with videos related to
Sort By:
Page
of 17
Journal of Geriatric Oncology
|
October 17, 2025
Response to letter to the editor: "Insights on nivolumab-based immunotherapy and prognostic stratification in older patients with metastatic renal cell carcinoma"
Veronica Murianni, Giuseppe Luigi Banna
The New England Journal of Medicine
|
October 23, 2024
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
Giuseppe Luigi Banna, Alfredo Addeo
Future Oncology (London, England)
|
August 14, 2015
How to develop novel treatments for EGFR-mutant lung cancer
Giuseppe Luigi Banna, Marcello Tiseo
Journal of Thoracic Disease
|
October 30, 2018
The crucial role of predicting brain metastases development in non-small cell lung cancer patients
Alfredo Addeo, Giuseppe Luigi Banna
Translational Lung Cancer Research
|
November 6, 2018
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Alfredo Addeo, Giuseppe Luigi Banna
Translational Lung Cancer Research
|
November 6, 2018
PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Alfredo Addeo, Giuseppe Luigi Banna
The Oncologist
|
December 14, 2020
ADAURA: Mature Enough for Publication, Not for Prime Time
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Cancer Research
|
February 4, 2022
Stepping in the right direction but still some ways to go
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Lung Cancer Research
|
August 12, 2022
From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer
Giuseppe Luigi Banna, Jarushka Naidoo, Alfredo Addeo
Tumori
|
July 8, 2009
Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy
Matteo Simonelli, Giuseppe Luigi Banna, Armando Santoro
Page
of 17